Elsevier

Annals of Oncology

Volume 29, Supplement 8, October 2018, Page viii735
Annals of Oncology

Late-breaking and deferred publication abstracts
Melanoma and other skin tumours
LBA44 - Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)

https://doi.org/10.1093/annonc/mdy424.054Get rights and content
Under an Elsevier user license
open archive

Cited by (0)